Benjamin Peter Kleinstiver BSc, PhD

Ben Kleinstiver is a Principal Investigator at the Massachusetts General Hospital (MGH) and Instructor at Harvard Medical School (HMS). His research interests are broadly focused on developing and improving genome editing technologies for biomedical research and clinical applications. The work in his laboratory is focused on using protein engineering methods to evolve genome editing nucleases that have enhanced properties. His research group is actively developing CRISPR enzymes with improved on-target activities, genome-wide specificities, and targeting ranges, and are also explore the feasibility of applying these engineered technologies for the treatment of genetic diseases.